Trials / Completed
CompletedNCT02622867
Lactobacillus Plantarum 3547 Effects Over Inflammatory and Immunologic Markers
Nutritional Intervention Clinical Trial to Evaluate the Lactobacillus Plantarum 3547 Probiotic Effects Over Different Inflammation and Immune System Markers in a Group of Healthy Middle-aged People
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz · Academic / Other
- Sex
- All
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effects of the probiotic Lactobacillus plantarum 3547 over different inflammation and immune system markers on a healthy middle-aged group.
Detailed description
In this randomized double blind controlled trial, a group of healthy middle-aged people (45 to 65 years old) had a nutritional intervention to evaluate the Lactobacillus plantarum 3547 probiotic effects over different inflammation and immune system markers, the experimental group took the experimental supplement (Lactobacillus plantarum 3547) during one period of parallel study (12 weeks), the volunteers consumed 1 capsule/daily with Lactobacillus plantarum 3547 (10x109 cfu/d) immediately after finishing their meal, the capsule contains: 77 mg probiotic Lp3547 and 390 mg maltodextrins. The control group took the control supplement (Maltodextrin) during one period of parallel study (12 weeks), volunteers consumed 1 daily capsule of maltodextrin without Lactobacillus plantarum 3547 (Placebo) immediately after finishing their meal. (The capsule contains 425 mg of maltodextrin)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lactobacillus plantarum 3547 | During one period of parallel study (12 weeks) volunteers consumed 1 capsule/daily with Lactobacillus plantarum 3547 immediately after finishing their meal. |
| DIETARY_SUPPLEMENT | Maltodextrin | During one period of parallel study (12 weeks), volunteers will consume 1 daily capsule of maltodextrin immediately after finishing their meal. |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-12-01
- First posted
- 2015-12-07
- Last updated
- 2015-12-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02622867. Inclusion in this directory is not an endorsement.